The U.S. Food and Drug Administration is reportedly planning to pull one of the market’s most popular brands of vape products.
The FDA could force Juul Labs Inc., the largest e-cigarette manufacturer in the US, to stop selling its products as early as this week, The Wall Street Journal reported, citing sources familiar with the decision. .
Juul Labs has been under FDA review since 2020, after the company filed an application to continue selling e-cigarette products in the US
The FDA review of Juul is part of the agency’s larger overhaul effort to review vaping products in an effort to analyze whether they pose a threat to public health. The review comes in response to public concerns that they are not as tightly regulated as other tobacco Products†
The FDA also responded to claims that Juul’s nicotine products, marketed with fruity flavors and celebrities, targeted teens and caused an increase in underage tobacco use, according to the Wall Street Journal.
The FDA is assessing the applications of all major e-cigarette companies in 2021 and 2022 on whether their products can induce tobacco users to quit and whether the benefits outweigh the health consequences for new users, including teens.
E-cigarettes are the most widely used tobacco product among college students in the US
a march study The FDA on Tobacco Use found that more than 2 million U.S. middle and high school students were consuming tobacco products monthly by 2021.
In 2019, the FDA’s Criminal Investigation Unit launched an investigation into e-cigarette companies after the products were linked to a nationwide outbreak of lung disease linked to vaping products.
The outbreak resulted in at least 530 illnesses and seven deaths, according to a report from the Centers for Disease Control and Prevention in September 2019.
Former Juul CEO Kevin Burns resigned that same year after receiving harsh criticism from those who feared the products were dangerous.
Juul also reduced its marketing efforts, shutting down its Facebook and Instagram pages, and stopped using fruit-flavored cartridges in 2019 as a show of goodwill toward the FDA and public health concerns.
Shares of tobacco company Altria, which produces Marlboro cigarettes and owns a 35% stake in Juul, fell 8% after the announcement, according to the guard†
HuffPost contacted the FDA for more information, but did not hear back in time for publication.